BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25481649)

  • 1. Targeting the Fas/FasL system in Rheumatoid Arthritis therapy: Promising or risky?
    Calmon-Hamaty F; Audo R; Combe B; Morel J; Hahne M
    Cytokine; 2015 Oct; 75(2):228-33. PubMed ID: 25481649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas.
    Hong S; Kim EJ; Lee EJ; San Koo B; Min Ahn S; Bae SH; Lim DH; Kim YG; Yoo B; Lee CK
    Life Sci; 2015 Feb; 122():37-41. PubMed ID: 25529148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct effects of soluble and membrane-bound fas ligand on fibroblast-like synoviocytes from rheumatoid arthritis patients.
    Audo R; Calmon-Hamaty F; Papon L; Combe B; Morel J; Hahne M
    Arthritis Rheumatol; 2014 Dec; 66(12):3289-99. PubMed ID: 25078097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
    Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
    Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications.
    Romano E; Manetti M; Peruzzi F; Melchiorre D; Milia AF; Bellando-Randone S; Nishioka K; Innocenti M; Carulli C; Linari S; Morfini M; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Haemophilia; 2014 Jan; 20(1):e32-9. PubMed ID: 24308756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis.
    Palao G; Santiago B; Galindo M; Payá M; Ramirez JC; Pablos JL
    Arthritis Rheum; 2004 Sep; 50(9):2803-10. PubMed ID: 15457448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules.
    Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Kato T; Hamada H; Nishioka K
    Arthritis Rheum; 2000 May; 43(5):1106-14. PubMed ID: 10817565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha regulation of the FAS-mediated apoptosis-signaling pathway in synovial cells.
    Kobayashi T; Okamoto K; Kobata T; Hasunuma T; Sumida T; Nishioka K
    Arthritis Rheum; 1999 Mar; 42(3):519-26. PubMed ID: 10088775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.
    Ohshima S; Mima T; Sasai M; Nishioka K; Shimizu M; Murata N; Yoshikawa H; Nakanishi K; Suemura M; McCloskey RV; Kishimoto T; Saeki Y
    Cytokine; 2000 Mar; 12(3):281-8. PubMed ID: 10704256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes.
    Gu X; Gu B; Lv X; Yu Z; Wang R; Zhou X; Qiao W; Mao Z; Zuo G; Li Q; Miao D; Jin J
    Cell Death Dis; 2016 Oct; 7(10):e2423. PubMed ID: 27763638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes.
    Kim WU; Yoo SA; Min SY; Park SH; Koh HS; Song SW; Cho CS
    Clin Exp Immunol; 2006 Jun; 144(3):503-11. PubMed ID: 16734620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anchorage on fibronectin via VLA-5 (alpha5beta1 integrin) protects rheumatoid synovial cells from Fas-induced apoptosis.
    Kitagawa A; Miura Y; Saura R; Mitani M; Ishikawa H; Hashiramoto A; Yoshiya S; Shiozawa S; Kurosaka M
    Ann Rheum Dis; 2006 Jun; 65(6):721-7. PubMed ID: 16249227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CD95 on inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
    Li X; Zhang Z; Peng A; He M; Xu J; Shen S; Zhuang J; Huang X
    Cell Immunol; 2014 Aug; 290(2):209-16. PubMed ID: 25084560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvia miltiorrhiza injection restores apoptosis of fibroblast-like synoviocytes cultured with serum from patients with rheumatoid arthritis.
    Liu QS; Luo XY; Jiang H; Xing Y; Yang MH; Yuan GH; Tang Z; Wang H
    Mol Med Rep; 2015 Feb; 11(2):1476-82. PubMed ID: 25352238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining.
    Yao Q; Glorioso JC; Evans CH; Robbins PD; Kovesdi I; Oligino TJ; Ghivizzani SC
    J Gene Med; 2000; 2(3):210-9. PubMed ID: 10894267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.
    Lories RJ; Derese I; Ceuppens JL; Luyten FP
    Arthritis Rheum; 2003 Oct; 48(10):2807-18. PubMed ID: 14558086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by proinflammatory cytokines of Fas/Fas ligand-mediated apoptotic cell death of synovial cells in patients with rheumatoid arthritis (RA).
    Wakisaka S; Suzuki N; Takeba Y; Shimoyama Y; Nagafuchi H; Takeno M; Saito N; Yokoe T; Kaneko A; Asai T; Sakane T
    Clin Exp Immunol; 1998 Oct; 114(1):119-28. PubMed ID: 9764613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease activity improvement in rheumatoid arthritis treated with tumor necrosis factor-α inhibitors correlates with increased soluble Fas levels.
    Romano E; Terenzi R; Manetti M; Peruzzi F; Fiori G; Nacci F; Bellando-Randone S; Matucci-Cerinic M; Guiducci S
    J Rheumatol; 2014 Oct; 41(10):1961-5. PubMed ID: 25179850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
    Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
    Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.